Nugen Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 08-07-2024
- Paid Up Capital ₹ 0.50 M
as on 08-07-2024
- Company Age 13 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 Cr
as on 08-07-2024
- Satisfied Charges ₹ 0.50 M
as on 08-07-2024
- Revenue 16.09%
(FY 2021)
- Profit 15.32%
(FY 2021)
- Ebitda 0.04%
(FY 2021)
- Net Worth 33.78%
(FY 2021)
- Total Assets 19.66%
(FY 2021)
About Nugen Laboratories
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹1.00 Cr. The company has closed loans amounting to ₹0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Rajendrakumar Donga and Jayeshbhai Asodariya serve as directors at the Company.
- CIN/LLPIN
U24230GJ2011PTC063874
- Company No.
063874
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Jan 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Nugen Laboratories Private Limited offer?
Nugen Laboratories Private Limited offers a wide range of products and services, including Disposable & Other Optical Lenses, Intraocular Lenses, Eye Diagnosis & Surgery Instruments, Eye Testing Machines.
Who are the key members and board of directors at Nugen Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajendrakumar Donga  | Director | 01-Aug-2012 | Current |
| Jayeshbhai Asodariya | Director | 31-Jan-2011 | Current |
Financial Performance of Nugen Laboratories.
Nugen Laboratories Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 16.09% increase. The company also saw a substantial improvement in profitability, with a 15.32% increase in profit. The company's net worth Soared by an impressive increase of 33.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nugen Laboratories?
In 2021, Nugen Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Acuvits Healthcare LlpActive 2 years 6 monthsRajendrakumar Donga and Jayeshbhai Asodariya are mutual person
- Tweeze Apparels LlpActive 1 year 1 month
Rajendrakumar Donga and Jayeshbhai Asodariya are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 15 Dec 2021 | ₹1.00 Cr | Open |
Others Creation Date: 02 Jul 2016 | ₹0.50 M | Satisfied |
How Many Employees Work at Nugen Laboratories?
Unlock and access historical data on people associated with Nugen Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nugen Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nugen Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
